First-in-class condensate-modulating small molecule Development Candidate targeting pathogenic TDP-43 condensates.Restores ...

iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference -- Participation underscores growing excitement around company's momentum and potential in precision oncology ...

32 Biosciences revealed its plan to launch a $40 million Series A at this year’s J.P Morgan Healthcare conference, to advance ...

In early December of 2025, researchers at the University of Calgary’s Quantum Nanophotonics Lab published a paper outlining a ...

Controlling light is an important technological challenge—not just at the large scale of optics in microscopes and telescopes ...

Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutationsKB407 transduction confirmed in all ...

32 Biosciences, a gastrointestinal (GI)-focused biotechnology company pioneering gut mucosal-immune science to prevent and treat GI diseases, today announced that it will officially launch its $40 ...

Detailed price information for Neumora Therapeutics Inc (NMRA-Q) from The Globe and Mail including charting and trades.

Detailed price information for Atossa Therapeutics Inc (ATOS-Q) from The Globe and Mail including charting and trades.

Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that it ...

Audeze Maxwell 2 (PlayStation) | $329.99 at PS Direct The PlayStation version of the Audeze Maxwell 2 is the most widely ...